ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing

October 10, 1980

Computer Learning May Help Women In Treatment Decision

October 30, 2009

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

About Face; NCI To Keep Preclinical AIDS Drug Development

December 12, 1986

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

MSK Withdraws Form Breast Cancer Nutrition Study Over Chemotherapy Issue; Program Still “Going Well”

June 21, 1985